微创内路三联手术治疗原发性开角型青光眼角膜内皮6个月安全性观察
回顾性病例系列研究纳入48例52只眼原发性开角型青光眼患者,观察3T手术前后角膜内皮细胞数量与形态变化。术后6个月内皮细胞数量与密度下降、平均细胞大小增加,六边形比率与中央角膜厚度无显著变化,未出现角膜内皮功能失代偿,短期安全性良好。
要点
- 内皮细胞数量减少、平均细胞大小增加,但六边形比率与中央角膜厚度无显著变化。
- 术后6个月随访未出现角膜内皮功能失代偿,短期安全性良好。
核心结论
- 3T手术治疗POAG虽造成角膜内皮细胞数量轻微减少、形态和大小改变,但术后6个月未引发角膜内皮功能失代偿,短期安全性良好。
研究设计与样本
- 回顾性病例系列研究,纳入2023年4月至2025年9月成都市第一人民医院眼科确诊POAG并接受3T手术的患者48例52只眼。
- 对比术前与术后6个月角膜内皮细胞数量、密度、平均细胞大小、六边形比率及中央角膜厚度,采用配对样本t检验分析。
主要发现
- 术前NUM为196±40个,术后6个月为170±56个,差异有统计学意义(P<0.05)。
- 术前AVG为381±76μm²,术后6个月为470±161μm²,差异有统计学意义(P<0.05)。
- 术前HEX为52%±9%,术后为50%±8%,差异无统计学意义(P>0.05);术前CCT为517±49μm,术后6个月为514±39μm,差异无统计学意义(P>0.05)。
临床怎么用
- 对接受3T手术的POAG患者,术后6个月内应关注角膜内皮细胞数量与形态变化,但短期内皮功能失代偿风险较低。
局限性
- 本研究为回顾性病例系列研究,样本量有限,随访时间仅6个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the safety of trabeculotome tunnelling trabeculoplasty (3T) in treating primary open-angle glaucoma (POAG) by observing the changes in corneal endothelial cell quantity and morphology after surgery. Methods: This was a retrospective case series study. Patients diagnosed with POAG who underwent successful 3T surgery were recruited from the Department of Ophthalmology, Chengdu First People's Hospital between April 2023 and September 2025. Parameters such as the number of cells, corneal endothelial cell density, average size, hexagonal cell ratio of endothelial cells, and central corneal thickness were recorded preoperatively and at 6 months postoperatively. Data were analyzed using the t-test. Results: The cohort comprised 48 patients, involving 52 eyes (27 left eyes, 25 right eyes), of whom 36 (75%) were male and 12 (25%) were female. The mean age of the patients was (51.37±12.90) years, ranging from 18 to 72 years. The preoperative number of cells was (196±40) cells, which decreased to (170±56) cells at 6 months postoperatively (P<0.05). The preoperative endothelial cell density was (2 686±416) cells/mm², compared to (2 302±563) cells/mm² at 6 months postoperatively (P<0.05). The average size increased from (381±76) μm² preoperatively to (470±161) μm² at 6 months postoperatively (P<0.05). The hexagonal cell ratio was (52±9)% preoperatively and (50±8)% at 6 months postoperatively, with no significant difference (P>0.05). The central corneal thickness was (517±49) μm preoperatively and (514±39) μm at 6 months postoperatively, with no significant difference (P>0.05). Conclusions: Although the 3T surgery for POAG results in a slight reduction in corneal endothelial cell count, as well as changes in corneal endothelial cell morphology and size, it does not induce corneal endothelial decompensation during the 6-month follow-up period and shows favorable short-term safety. 目的: 探讨新型微创内路三联(3T)手术治疗原发性开角型青光眼(POAG)对角膜内皮细胞的安全性。 方法: 回顾性病例系列研究。纳入2023年4月至2025年9月期间在成都市第一人民医院眼科确诊为POAG并接受3T手术患者的病例资料。对比患者术前及术后6个月的角膜内皮细胞数量(NUM)、角膜内皮细胞密度(ECD)、平均细胞大小(AVG)、六边形比率(HEX),中央角膜厚度(CCT)。采用配对样本t检验进行统计分析。 结果: 共纳入患者48例(52只眼),其中27只左眼,25只右眼;女性12例(25%),男性36例(75%);年龄为(51.37±12.90)岁,年龄范围为18~72岁。术前NUM为(196±40)个,术后6个月为(170±56)个;术前ECD为(2 686±416)个/mm2,术后6个月为(2 302±563)个/mm2;术前AVG为(381±76)μm2,术后6个月为(470±161)μm2;术前与术后6个月相比,差异均有统计学意义(均P<0.05)。术前HEX为52%±9%,术后为50%±8%;术前CCT为(517±49)μm,术后6个月为(514±39)μm;术前与术后6个月相比,差异均无统计学意义(均P>0.05)。 结论: 3T手术治疗POAG虽会造成角膜内皮细胞数量轻微减少,形态和大小有所改变,但术后6个月未引发角膜内皮功能失代偿,短期安全性良好。.
引用
- Huang XD, Qiu Q, Wang SZ, et al. [Clinical observation of the 6-month safety of the corneal endothelium after trabeculotome tunnelling trabeculoplasty surgery]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 41820065. doi:10.3760/cma.j.cn112142-20251031-00454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。